MDxHealth S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MXDHF research report →
About the company
MDxHealth SA operates as a commercial-stage precision diagnostics company, specializing in urological solutions for markets across the United States, various European nations (including the Netherlands, Belgium, Spain, Poland, and Italy), the broader European Union, and other international territories. The firm's innovative portfolio includes two genomic tests for prostate cancer: SelectMDx, a non-invasive urine-based diagnostic, and ConfirmMDx, an epigenetic test. These offerings provide medical professionals with a reliable method to identify clinically significant prostate cancer, thereby reducing the reliance on potentially complicated invasive procedures.
- CEO
- Michael K. McGarrity
- IPO
- 2014
- Employees
- 252
- HQ
- Herstal, BE
Price Chart
- Market Cap
- $8.65M
- P/E
- -0.71
- P/S
- 0.30
- P/B
- -1.97
- EV/EBITDA
- -15.17
- Div Yield
- 0.00%
- Gross Margin
- 57.68%
- Op Margin
- -16.59%
- Net Margin
- -32.17%
- ROE
- 402.97%
- ROIC
- -12.74%
- Revenue
- $107.88M · 19.80%
- Net Income
- $-33,519,000 · 11.95%
- EPS
- $-0.67 · 14.10%
- Op Income
- $-15,401,000
- FCF YoY
- 44.06%
- 52W High
- $0.65
- 52W Low
- $0.00
- 50D MA
- $0.33
- 200D MA
- $0.14
- Beta
- 0.73
- Avg Volume
- 39
Get TickerSpark's AI analysis on MXDHF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 18, 26 | OConnell Brendan | other | 0 |
| Mar 18, 26 | Bednarski Eric | other | 0 |
| Mar 18, 26 | Bellano John | other | 20,000 |
| Mar 18, 26 | Bellano John | other | 65,000 |
| Mar 18, 26 | Bellano John | other | 200,000 |
| Mar 18, 26 | McGarrity Michael | other | 0 |
| Mar 18, 26 | McGarrity Michael | other | 50,000 |
| Mar 18, 26 | McGarrity Michael | other | 186,875 |
| Mar 18, 26 | McGarrity Michael | other | 500,000 |
| Mar 18, 26 | Sollee Joseph | other | 20,000 |
Our MXDHF coverage
Recent articles, reports, and earnings notes.
No research on MXDHF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MXDHF report →Similar companies
Peers in the same neighborhood.